REX-8756 is a potent and selective oral STAT6 inhibitor that has shown complete 100% pathway inhibition and potent efficacy in…
REX-8756 is a potent and selective oral STAT6 inhibitor that has shown complete 100% pathway inhibition and potent efficacy in…
Geneva PE's funding of NXXIM will create a cutting-edge AI platform that unifies patient data and empowers clinicians to make…
Toronto, Ontario--(Newsfile Corp. - December 10, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) ("Quantum BioPharma" or…
Industry collaboration leads to significant improvements in CY 2026 Final Rule but long-term stability remains uncertainDALLAS, Dec. 10, 2025 /PRNewswire/…
Expanding its Portfolio with American Amnion to Serve the Wound Care Needs of Our VeteransPOMPANO BEACH, Fla., Dec. 10, 2025…
Expanding its Portfolio with American Amnion to Serve the Wound Care Needs of Our VeteransPOMPANO BEACH, Fla., Dec. 10, 2025…
Oversubscribed round demonstrates strong investor confidence in Lin Health's neuroscience-based approach to chronic painDENVER, Dec. 9, 2025 /PRNewswire/ -- Lin…
Markham, Ontario--(Newsfile Corp. - December 8, 2025) - Cheelcare (TSXV: CHER), a Canadian innovator in advanced mobility solutions, is proud…
A roundup of the most newsworthy healthcare press releases from PR Newswire, including new company mergers, Alzheimer's fundraising and advances…